Grit Biotechnology
Clinical trials sponsored by Grit Biotechnology, explained in plain language.
-
New immune cell therapy takes on advanced cancers
Disease control Not yet recruitingThis early-stage study is testing a new treatment called GT307 for people with advanced solid tumors that have spread or come back after standard therapy. GT307 uses a patient's own immune cells (tumor-infiltrating lymphocytes) to fight the cancer. The main goals are to see if th…
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New cell shot aims to tame immune attacks on kidneys
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy called GT719 in about 30 adults with kidney diseases caused by the immune system, such as IgA nephropathy and membranous nephropathy. The study has two phases: first, finding a safe dose, then testing that dose in more people. The m…
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 13, 2026 16:02 UTC